1. Home
  2. ROIV vs WCC Comparison

ROIV vs WCC Comparison

Compare ROIV & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • WCC
  • Stock Information
  • Founded
  • ROIV 2014
  • WCC 1922
  • Country
  • ROIV United Kingdom
  • WCC United States
  • Employees
  • ROIV N/A
  • WCC N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • WCC Telecommunications Equipment
  • Sector
  • ROIV Health Care
  • WCC Consumer Discretionary
  • Exchange
  • ROIV Nasdaq
  • WCC Nasdaq
  • Market Cap
  • ROIV 7.8B
  • WCC 8.1B
  • IPO Year
  • ROIV N/A
  • WCC 1999
  • Fundamental
  • Price
  • ROIV $10.99
  • WCC $167.86
  • Analyst Decision
  • ROIV Buy
  • WCC Buy
  • Analyst Count
  • ROIV 4
  • WCC 8
  • Target Price
  • ROIV $17.50
  • WCC $212.00
  • AVG Volume (30 Days)
  • ROIV 5.1M
  • WCC 635.2K
  • Earning Date
  • ROIV 05-29-2025
  • WCC 05-01-2025
  • Dividend Yield
  • ROIV N/A
  • WCC 1.08%
  • EPS Growth
  • ROIV N/A
  • WCC 10.34
  • EPS
  • ROIV N/A
  • WCC 13.26
  • Revenue
  • ROIV $29,053,000.00
  • WCC $21,812,500,000.00
  • Revenue This Year
  • ROIV N/A
  • WCC $4.13
  • Revenue Next Year
  • ROIV N/A
  • WCC $4.27
  • P/E Ratio
  • ROIV N/A
  • WCC $12.66
  • Revenue Growth
  • ROIV N/A
  • WCC N/A
  • 52 Week Low
  • ROIV $8.73
  • WCC $125.21
  • 52 Week High
  • ROIV $13.06
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 52.59
  • WCC 52.67
  • Support Level
  • ROIV $10.59
  • WCC $161.70
  • Resistance Level
  • ROIV $11.37
  • WCC $175.36
  • Average True Range (ATR)
  • ROIV 0.32
  • WCC 4.00
  • MACD
  • ROIV -0.01
  • WCC -0.29
  • Stochastic Oscillator
  • ROIV 52.23
  • WCC 41.51

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About WCC WESCO International Inc.

Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.

Share on Social Networks: